CAMARADES: Bringing evidence to translational medicine Evidence based translational medicine Experimental Studies Systematic review and meta-analysis how.

Slides:



Advertisements
Similar presentations
Study Quality and Publication Bias in Experimental Stroke
Advertisements

CAMARADES: Bringing evidence to translational medicine Study Quality and Publication Bias in Experimental Studies of Neurological Diseases Emily S Sena,
Summarising what we already know – the pivotal role of systematic reviews Malcolm Macleod.
HAIST HAIST The Hypothermia for Acute Ischaemic Stroke Trial Malcolm Macleod PhD FRCPE Senior Lecturer, Clinical Neurosciences, University of Edinburgh.
Summarising the evidence from animal models of neurological disease: Publication bias, poor internal validity, and (perhaps) some efficacy Malcolm Macleod.
Modelling Stroke in the Laboratory - Separating Fact from Artefact The impact of sources of bias in animal models of neurological disease, and what we.
Improving the internal validity of experiments in focal ischaemia
Summarising the evidence from animal models of neurological disease: Publication bias, poor internal validity, and (perhaps) some efficacy Malcolm Macleod.
CAMARADES: Bringing evidence to translational medicine The failure to translate the basic science into therapy is due primarily to inadequacies in the.
Telephone based self-management support for vascular conditions via non-healthcare professionals: a systematic review and meta-analysis Dr Nicola Small,
CAMARADES: Bringing evidence to translational medicine The effect of anaesthetics on the developing neonatal brain: A systematic review and meta-analysis.
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
David Howells For the CAMARADES Collaboration STAIR A starting point for evidence-based translational medicine in stroke.
Systematic reviews of animal studies Malcolm Macleod.
CAMARADES: Bringing evidence to translational medicine Optimizing the Predictive Value of Pre-Clinical Research Session 3: Reviewer Perspective Malcolm.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Oxygen Saturation Target Range for Extremely Preterm Infants Manja V, Lakshminrusimha.
The third international stroke trial (IST-3) of thrombolysis main results III. Effect of iv thrombolysis with iv rt-PA on death or dependency in the 3035.
St John’s wort for major depression (Review) Linde, Berner & Kriston (2008/9)
Journal Club Alcohol and Health: Current Evidence July-August 2006.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2014.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Experimental Study.
RANDOMIZED CLINICAL TRIALS. What is a randomized clinical trial?  Scientific investigations: examine and evaluate the safety and efficacy of new drugs.
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
Felix I. Zemel, MPH DrPH Student Tufts University School of Medicine.
Howard Fillit, MD Executive Director Improving Animal Trials for Alzheimer’s Disease: Recommendations for Best Practices.
Making all research results publically available: the cry of systematic reviewers.
THERAPEUTIC HYPOTHERMIA Heike Geduld August 2007.
Are the results valid? Was the validity of the included studies appraised?
Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy: An Updated Systematic Review and Meta-analysis Tagin MA, Woolcott CG, Vincer MJ, Whyte RK, Stinson.
Types of clinical studies Thomas Abraham. Three broad types of studies: used for different purposes 1. Observational (observe groups of people, gather.
Dr. Amer Jafar.  Previous studies showed that a positive family history of stroke (FHstroke) is an independent risk factor for lacunar stroke  The aim.
دکتر خلیلی 1. Lucid the way to “ Research” And Follow an “ Evidence Based Medicine”
CAMARADES: Bringing evidence to translational medicine What could be going wrong? Randomisation and blinding.
Evidence Based Medicine Meta-analysis and systematic reviews Ross Lawrenson.
Placebo-Controls in Short-Term Clinical Trials of Hypertension Sana Al-Khatib, MD, MHS Assistant Professor of Medicine Division of Cardiology Duke University.
What’s on the horizon? Peter Sandercock ESC Lisbon 23rd May 2012.
Developing Quality Indicators & Dashboards for Dementia Adam Cook South East Coast Quality Observatory.
Successful Concepts Study Rationale Literature Review Study Design Rationale for Intervention Eligibility Criteria Endpoint Measurement Tools.
Animal Models of Stroke Are they valuable for discovering neuroprotective agents? Wu Li-ping
CLINICAL TRIALS IN NEW DRUG DEVELOPMENT Michael A Ross,M.D. President CPL Inc.
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.
Specialised Geriatric Services Heather Gilley Sharon Straus.
How to read a paper D. Singh-Ranger. Academic viva 2 papers 1 hour to read both Viva on both papers Summary-what is the paper about.
Thrombolysis for patients > 80 – a different view Peter Sandercock On behalf of the IST3 collaborative Group UKSF Glasgow 1 st December 2009.
Third International Stroke Trial (IST-3): response to ECASS-3 results Professor Peter Sandercock, University of Edinburgh Collaborators Meeting Vienna.
Objectives  Identify the key elements of a good randomised controlled study  To clarify the process of meta analysis and developing a systematic review.
New book reveals Charles's seven egg habit Maev Kennedy Saturday September 23, 2006 The Guardian The Guardian With power comes the obligation to reach.
1 Lecture 10: Meta-analysis of intervention studies Introduction to meta-analysis Selection of studies Abstraction of information Quality scores Methods.
Is the conscientious explicit and judicious use of current best evidence in making decision about the care of the individual patient (Dr. David Sackett)
Of Chiropractic Clinical Research Palmer Center for Chiropractic Research.
Thrombolysis for acute ischaemic stroke Clinical
Types of Studies. Aim of epidemiological studies To determine distribution of disease To examine determinants of a disease To judge whether a given exposure.
HTA Efficient Study Designs Peter Davidson Head of HTA at NETSCC.
Thrombolysis: The Evidence Barry Moynihan Stroke Physician, St. George’s Hospital SITS/BASP Thrombolysis Nursing Training Day March 26 th 2012.
IST-3, SITS MOST ECASS-3 & DEFUSE Professor Peter Sandercock University of Edinburgh, UK ESC May 30 th 2007 Glasgow Competing interests:
1 Lecture 10: Meta-analysis of intervention studies Introduction to meta-analysis Selection of studies Abstraction of information Quality scores Methods.
Is a meta-analysis right for me? Jaime Peters June 2014.
Chicago 2014 TFQO: Clifton Callaway # EVREV 1: Janice Zimmerman # EVREV 2: Jonathan Sullivan COI # Taskforce: ALS ALS 790 : Induced Hypothermia.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
Article Title Resident Name, MD SVCH6/13/2016 Journal Club.
Evidence-Based Mental Health PSYC 377. Structure of the Presentation 1. Describe EBP issues 2. Categorize EBP issues 3. Assess the quality of ‘evidence’
What are the most effective treatment approaches to use to reduce fatigue for people with Multiple Sclerosis? A critical appraisal of the literature Samantha.
The Stages of a Clinical Trial
Systematic review an overview and posing the question
Reporting quality in preclinical studies Emily S Sena, PhD Centre for Clinical Brain Sciences, University of
Endovascular Selective Cerebral Hypothermia for Neuroprotection
Treating Disease Learning Objectives: Describe how antibiotics work.
Associate Fellow, Centre for Evidence-based Medicine, Oxford
Presentation transcript:

CAMARADES: Bringing evidence to translational medicine Evidence based translational medicine Experimental Studies Systematic review and meta-analysis how powerful is the treatment? what is the quality of evidence? what is the range of evidence? is there evidence of a publication bias? What are the conditions of maximum efficacy? Clinical trial

CAMARADES: Bringing evidence to translational medicine Cooling for stroke Cooling seems to work in patients who have brain injury due to cardiac arrest There’s lots of stories about individual patients who should have extensive brain damage but don’t Many labs use cooling as a positive control in their animal studies Preliminary evidence from clinical trials in stroke is encouraging

CAMARADES: Bringing evidence to translational medicine 43.5% protection ( ) How powerful is the treatment in animals? 101 publications 222 experiments 3256 animals

CAMARADES: Bringing evidence to translational medicine Evidence based clinical trial design Hypothermia for acute ischaemic stroke CriterionAnimal dataEuroHYP-1 How powerful is the treatment? >40% improvement in outcome Powered to detect 7% improvement in outcome What is the quality of evidence? Efficacy maintained in high quality studies Randomised, blinded outcome assessment, intensely monitored Is there evidence of a publication bias? Yes, but >35% improvement in adjusted outcome Registered What is the range of evidence? Good: duration of cooling, delay to treatment, intensity, hypertension, reperfusion Patients >18yo with moderate to severe stroke treated within 6 hrs What are the conditions of maximum efficacy? Temperature dependent: otherwise robust across dimensions Target 34-35°C

CAMARADES: Bringing evidence to translational medicine

Evidence based translational medicine Experimental Studies Systematic review and meta-analysis how powerful is the treatment? what is the quality of evidence? what is the range of evidence? is there evidence of a publication bias? What are the conditions of maximum efficacy? Multi Centre Animal Studies confirm efficacy robust and monitored conduct of experiments transparent analysis and reporting deliberate heterogeneity Clinical trial

CAMARADES: Bringing evidence to translational medicine Data: More are better NXY-059 Hypothermia Cumulative meta- analysis of the efficacy of lytic treatments (eg tPA) in thrombotic animal models of stroke

CAMARADES: Bringing evidence to translational medicine Clinical trials and in vivo studies

CAMARADES: Bringing evidence to translational medicine MultiPART Multicentre Preclinical Animal Research Team

CAMARADES: Bringing evidence to translational medicine What we’ve found out so far … Animal studies which do not report simple measures to avoid bias give larger estimates of how good drugs are Most animal studies do not report simple measures to reduce bias Publication and selective outcome reporting biases are important and prevalent You cannot assume rigour, even in Journals of “impact” You can only find these things out by studying large numbers of studies

CAMARADES: Bringing evidence to translational medicine What we’re looking into now… Can we advise scientists on more efficient research design? Can we use this approach better to understand animal models of mental illness? Can we automate some of the techniques required? Can we help publishers improve quality? 3000 publications are added to PubMed each day– can we build tools to provide up-to-date research summaries? Can we use this approach to design better clinical trials?

CAMARADES: Bringing evidence to translational medicine Deaths from Stroke, Scotland Age 70 to 79

CAMARADES: Bringing evidence to translational medicine George Santayana “Those who cannot remember the past are condemned to repeat it” Abraham Maslow “To a man with a hammer, every problem looks like a nail” Karl Marx “Hegel said somewhere that history tends to repeat itself. He forgot to add that the first time is tragedy, the second is farce”

CAMARADES: Bringing evidence to translational medicine

Acknowledgements